Aspaveli receives positive CHMP opinion for treatment of paroxysmal nocturnal haemoglobinuria – SOBI + Apellis Pharma
Swedish Orphan Biovitrum AB (publ) (Sobi) and Apellis Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted… read more.
